Key Takeaways
- • GC Angels deployed £1.87m across four investments in March 2026, with two deals originating from its inaugural Venture Forward accelerator programme supporting underrepresented founders across Northern England.
- • Breezemove, a UK PropTech platform streamlining home-buying processes, secured a six-figure investment from GC Angels as part of a £750,000 seed round.
- • MissionC, a premium wellness brand offering FSA-regulated CBD, functional mushroom, and Shilajit products stocked by Selfridges and Holland & Barrett, received a £345,000 investment led by GC Angels.
- • The Venture Forward programme, funded by Innovate UK, has successfully generated a pipeline of high-quality investment opportunities, with the first cohort (October–December 2025) resulting in nine companies raising over £2.5m in total funding.
- • Two additional investments were made into existing GC Angels portfolio companies, demonstrating continued momentum and conviction in the fund's portfolio strategy.
Summary
GC Angels, the venture capital investment arm of the Growth Company based in Manchester, announced four new investments totalling £1.87m in March 2026. The deployment reflects a dual strategy combining capital deployment from its flagship Venture Forward accelerator programme alongside follow-on investments in established portfolio companies.
Two of the four deals originated from GC Angels' inaugural Venture Forward cohort, which operated from October through December 2025. The programme, funded by Innovate UK, targets underrepresented founders across Northern England, providing structured support as companies prepare for institutional investment rounds. Breezemove, a PropTech platform designed to streamline and simplify the home-buying process, received a six-figure investment from GC Angels as part of a broader £750,000 seed round. MissionC, a premium wellness brand offering lab-tested and FSA-regulated CBD, functional mushroom, and Shilajit products, secured £345,000 in funding led by GC Angels. MissionC's distribution through leading retailers including Selfridges and Holland & Barrett demonstrates commercial traction ahead of institutional funding.
The Venture Forward programme has established itself as a consistent pipeline for investment opportunities. The first cohort generated nine companies that collectively raised over £2.5m in funding, validating the accelerator's selection process and support model. Alongside these new commitments, GC Angels completed two further investments into existing portfolio companies, underscoring the fund's ongoing conviction in its backed businesses and its capacity to support portfolio companies through multiple funding rounds.
The investments signal sustained venture capital activity in the North of England and a focus on sectors spanning PropTech and wellness innovation. The emphasis on underrepresented founders addresses a structural gap in institutional venture capital allocation, positioning the Venture Forward programme as a differentiated sourcing mechanism for early-stage opportunities.
Two of the four deals originated from GC Angels' inaugural Venture Forward cohort, which operated from October through December 2025. The programme, funded by Innovate UK, targets underrepresented founders across Northern England, providing structured support as companies prepare for institutional investment rounds. Breezemove, a PropTech platform designed to streamline and simplify the home-buying process, received a six-figure investment from GC Angels as part of a broader £750,000 seed round. MissionC, a premium wellness brand offering lab-tested and FSA-regulated CBD, functional mushroom, and Shilajit products, secured £345,000 in funding led by GC Angels. MissionC's distribution through leading retailers including Selfridges and Holland & Barrett demonstrates commercial traction ahead of institutional funding.
The Venture Forward programme has established itself as a consistent pipeline for investment opportunities. The first cohort generated nine companies that collectively raised over £2.5m in funding, validating the accelerator's selection process and support model. Alongside these new commitments, GC Angels completed two further investments into existing portfolio companies, underscoring the fund's ongoing conviction in its backed businesses and its capacity to support portfolio companies through multiple funding rounds.
The investments signal sustained venture capital activity in the North of England and a focus on sectors spanning PropTech and wellness innovation. The emphasis on underrepresented founders addresses a structural gap in institutional venture capital allocation, positioning the Venture Forward programme as a differentiated sourcing mechanism for early-stage opportunities.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.